Literature DB >> 12076877

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

Masahiko Shimada1, Etsuko Hashimoto, Makiko Taniai, Kiyoshi Hasegawa, Hiroaki Okuda, Naoaki Hayashi, Ken Takasaki, Jurgen Ludwig.   

Abstract

We describe six patients with non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). From 1990 to 2001, we treated 82 patients with NASH and observed six patients (three men and three women, aged 56-72 years) in this group who were referred with HCC or developed the complication during follow-up. In five of these six patients, NASH was associated with obesity (cases 3, 4 and 5), hyperlipidemia (case 5), or diabetes mellitus (cases 1, 3 and 6). We confirmed the presence of HCC by ultrasonography-guided tumor biopsy or surgery except in case 3 where we diagnosed the tumor by ultrasonography, computed tomography and selective hepatic arteriography. The carcinomas measured 1.5-6.0 cm in diameter and three were well differentiated. When HCC was diagnosed, cirrhosis was present in all instances. Four of the six tumor patients also had esophageal varices but only one patient had a history of variceal bleeding and ascites. Treatment of HCC consisted of surgery (cases 1 and 5), transcatheter arterial embolization or infusion and/or percutaneous ethanol injection (cases 2, 3, 4, and 6). In patients with NASH cirrhosis, the development of treatable HCC is sufficiently common to warrant regular screening for this grave complication.

Entities:  

Mesh:

Year:  2002        PMID: 12076877     DOI: 10.1016/s0168-8278(02)00099-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  74 in total

1.  Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Pavel Vladimirovich Korita; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

2.  Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Mitsuhito Koizumi; Shinya Furukawa; Teruhisa Ueda; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-02-14       Impact factor: 7.527

3.  Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?

Authors:  Satoru Yatsuji; Etsuko Hashimoto; Hiroyuki Kaneda; Makiko Taniai; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

4.  Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis.

Authors:  Shiro Yokohama; Yoshihiko Tokusashi; Kimihide Nakamura; Yosui Tamaki; Satoshi Okamoto; Mituyoshi Okada; Kazunobu Aso; Takenao Hasegawa; Masaru Aoshima; Naoyuki Miyokawa; Masakazu Haneda; Masashi Yoneda
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

5.  High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.

Authors:  Michal Ganz; Timea Csak; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

7.  Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease.

Authors:  Jianmei Zhang; Wenbin Chen; Li Fang; Qiu Li; Xu Zhang; Haiqing Zhang; Qingbo Guan; Rang Zhao; Chongbo Yang; Fei Jing
Journal:  Wien Klin Wochenschr       Date:  2018-05-29       Impact factor: 1.704

8.  Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C.

Authors:  Atsushi Tanaka; Satoko Uegaki; Hiroko Kurihara; Kiyoshi Aida; Masaki Mikami; Ikuo Nagashima; Junji Shiga; Hajime Takikawa
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 9.  Nonalcoholic steatohepatitis in children.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

10.  Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Authors:  Etsuko Hashimoto; Satoru Yatsuji; Maki Tobari; Makiko Taniai; Nobuyuki Torii; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.